Literato, Anna Rose .
HRN: 27-10-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2025
CEFUROXIME 1.5GM (VIAL)
07/21/2025
07/22/2025
IV
1.5gm
Q8hr X 3 Doses
UTI
Checking Initial Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines